510(k) Report

510(k) · Decided

Decided

Cordis Palmaz Corinthian Transhepatic Biliary Stent and Accessories

K991028510(k) TraditionalDecided Aug 4, 1999128-day reviewClass II21 CFR 876.5010

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Cordis Corp. · FGE Stents, Drains And Dilators For The Biliary Ducts

Cleared on Aug 4, 1999 as substantially equivalent to K905720 (Johnson & Johnson Interventional Systems, 1991) and 5 other predicates after a 128-day review. Its family tree reaches back 2 generations to 1991. 19 later devices descend from it.

Decided
Aug 4, 1999
Review
128 days
Class
Class II
Product code
FGE
Recalls
None
Predicates
6

Its longest line of descent runs back 2 generations to K905720 (1991). 6 ancestors in all. 19 later devices descend from it, 3 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1998: 1 other ancestor1997: 2 other ancestors1991: 1 other ancestor2001: 4 descendants cleared1999: 1 descendant cleared2002: 2 descendants cleared2003: 4 descendants cleared2010: 1 descendant cleared2004: 3 descendants cleared2000: 1 descendant cleared2014: 1 descendant cleared2006: 1 descendant cleared2007: 1 descendant clearedK905720 · Palmaz Biliary Stent · Johnson & Johnson Interventional Systems · 1991K990631 · Cordia Palmaz Corinthian Transhepatic Biliary Stent and Delivery System, Model PC125BPS, PC126BPS, PC127BPS,PC128BPS, PC · Cordis Corp. · 19991990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 4 other ancestors 1 generation forward: 3 descendants2 generations forward: 8 descendants3 generations forward: 6 descendants4 generations forward: 1 descendant5 generations forward: 1 descendant K990631 · Cordia Palmaz Corinthian Transhepatic Biliary Stent and Delivery System, Model PC125BPS, PC126BPS, PC127BPS,PC128BPS, PC · Cordis Corp. · 1999K905720 · Palmaz Biliary Stent · Johnson & Johnson Interventional Systems · 19910+5
  1. Root · 2 generations backK905720 Palmaz Biliary StentJohnson & Johnson Interventional Systems · 1991
  2. 1 generation backK990631 Cordia Palmaz Corinthian Transhepatic Biliary Stent and Delivery…Cordis Corp. · 1999
  3. This deviceK991028 Cordis Palmaz Corinthian Transhepatic Biliary Stent and AccessoriesCordis Corp. · 1999
  4. Descendant · cites it directly · 17 of its ownK992755 Cordis Palmaz Corinthian Transhepatic Biliary Stent and Delivery…Cordis, A Johnson & Johnson Co. · 1999
  5. Descendant · 2 generations on · 11 of its ownK994156 Modification to Cordis Palmaz Corinthian IQ Transhepatic Biliary…Cordis Corp. · 2000
  6. Descendant · 2 generations on · 9 of its ownK012056 Cordis Palmaz Genesis Transhepatic Biliary Stent on Slalom .018…Cordis Europa, N.V. · 2001
  7. Descendant · cites it directly · 6 of its ownK012090 Cordis Palmaz Genesis Transhepatic Biliary StentCordis, A Johnson & Johnson Co. · 2001
  8. Descendant · cites it directly · 5 of its ownK012590 Cordis Palmaz Genesis Transhepatic Biliary Stent on Opta Pro .035…Cordis Corp. · 2001

Showing 5 of 19 descendants. See all descendants

Descendants cleared per year

1999: 12000: 12001: 42002: 22003: 42004: 32006: 12007: 12010: 12014: 1
1999high 4 (2001) · low 0 (2005)2026

Most influential descendants

Showing 5 of 19 · See all
  • K992755Cordis Palmaz Corinthian Transhepatic Biliary Stent and Delivery System, Cordis Crimping…Cordis, A Johnson & Johnson Co. · 1999 · cites it directly17descendants
  • K994156Modification to Cordis Palmaz Corinthian IQ Transhepatic Biliary Stent, Models PQ294B…Cordis Corp. · 2000 · 2 generations on11descendants
  • K012056Cordis Palmaz Genesis Transhepatic Biliary Stent on Slalom .018 Delivery SystemCordis Europa, N.V. · 2001 · 2 generations on9descendants
  • K012090Cordis Palmaz Genesis Transhepatic Biliary StentCordis, A Johnson & Johnson Co. · 2001 · cites it directly6descendants
  • K012590Cordis Palmaz Genesis Transhepatic Biliary Stent on Opta Pro .035 Delivery SystemCordis Corp. · 2001 · cites it directly5descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K905720Palmaz Biliary StentJohnson & Johnson Interventional Systems1991—
−1K990631Cordia Palmaz Corinthian Transhepatic Biliary Stent and Delivery System, Model…Cordis Corp.1999—
0 (this device)K991028Cordis Palmaz Corinthian Transhepatic Biliary Stent and AccessoriesCordis Corp.1999—
+1K992755Cordis Palmaz Corinthian Transhepatic Biliary Stent and Delivery System…Cordis, A Johnson & Johnson Co.1999—
+2K994156Modification to Cordis Palmaz Corinthian IQ Transhepatic Biliary Stent, Models…Cordis Corp.2000—
+2K012056Cordis Palmaz Genesis Transhepatic Biliary Stent on Slalom .018 Delivery SystemCordis Europa, N.V.2001—
+1K012090Cordis Palmaz Genesis Transhepatic Biliary StentCordis, A Johnson & Johnson Co.2001—
+1K012590Cordis Palmaz Genesis Transhepatic Biliary Stent on Opta Pro .035 Delivery…Cordis Corp.2001—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199110
199720
199810

Descendants by year cleared

Year clearedDevicesWith a Class I recall
199910
200010
200140
200220
200340
200430
200610
200710
201010
201410
FIG. 1 — Lineage of K991028, 1991–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FGE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FGE device

  1. #1 K240464 WallFlex Biliary RX Stent System; Epic Biliary…score 14.5 · 13 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (6)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K905720Palmaz Biliary Stent
Summary page 1
…featured with the Cordis PALMAZ CORINTHIAN Transhepatic Biliary Stent are substantially equivalent to those featured among predecessor Cordis biliary stents (see 510(k) #K905720, #K911581, and #K964688). Page | oy 1/ - Pfi—g& 2{» Cordis Cur purativn SIO(K) #K991028 PALMAZ CORINTHIAN Trans…
Johnson & Johnson Interventional Systems1991—
*K911581Palmaz (TM) Balloon-Expandable Stent, Modification
Summary page 1
…ith the Cordis PALMAZ CORINTHIAN Transhepatic Biliary Stent are substantially equivalent to those featured among predecessor Cordis biliary stents (see 510(k) #K905720, #K911581, and #K964688). Page | oy 1/ - Pfi—g& 2{» Cordis Cur purativn SIO(K) #K991028 PALMAZ CORINTHIAN Transhepatic Bi…
Johnson & Johnson Interventional Systems1991—
*K964688Long Medium Palmaz-Schatz Balloon Expandable Stent
Summary page 1
…PALMAZ CORINTHIAN Transhepatic Biliary Stent are substantially equivalent to those featured among predecessor Cordis biliary stents (see 510(k) #K905720, #K911581, and #K964688). Page | oy 1/ - Pfi—g& 2{» Cordis Cur purativn SIO(K) #K991028 PALMAZ CORINTHIAN Transhepatic Biliary Stent an…
Cordis Corp.1997—
*K990631Cordia Palmaz Corinthian Transhepatic Biliary Stent and Delivery System, Model PC125BPS…
Cleared while this submission was under review
Summary page 2
…ry Stent reprecents a line extension to other Cordis balloon catheters that were previously determined substantially equivalent for biliary stent deployment (see 510(k) #K990631). Device Description: The Cordis PALMAZ CORINTHIAN Transhepatic Biliary Stent is a balloon- expandable, stainless steel stent t…
Cordis Corp.1999—
*K971448Cordis Opta LP Pta Balloon Catheter
Summary page 2
…nt of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. This is the same intended use previously cleared for this balloon catheter (via 510(k) #K971448 and #K981407). Technological Characteristics: The Cordis PALMAZ CORINTHIAN Transhepatic Biliary Stent incorporates the same met…
Cordis Corp.1997—
*K981407Opta LP Pta Balloon Catheter/Powerflex Plus Pta Balloon Catheter
Summary page 2
…tive lesions of native or synthetic arteriovenous dialysis fistulae. This is the same intended use previously cleared for this balloon catheter (via 510(k) #K971448 and #K981407). Technological Characteristics: The Cordis PALMAZ CORINTHIAN Transhepatic Biliary Stent incorporates the same method of deploy…
Cordis Corp.1998—

Also cleared against K905720: 9 other devices →

What descends from it? (19)

See all 19

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K992755Cordis Palmaz Corinthian Transhepatic Biliary Stent and Delivery System, Cordis Crimping…Cordis, A Johnson & Johnson Co.199917
K012090Cordis Palmaz Genesis Transhepatic Biliary StentCordis, A Johnson & Johnson Co.20016
K012590Cordis Palmaz Genesis Transhepatic Biliary Stent on Opta Pro .035 Delivery SystemCordis Corp.20015

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 8 years and passes through 2 companies; a new generation was cleared every 8.2 years on median.
  • None of the 6 ancestors has a recall.
  • Of its descendants, K992755 (Cordis, A Johnson & Johnson Co., 1999) has gone furthest, with 17 descendants of its own.
  • 9 other devices also cite its predicate K905720.

How does its category compare?

All FGE devices

FGE Stents, Drains And Dilators For The Biliary Ducts: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · FGE

7in 2025

2007: 42008: 112009: 72010: 92011: 92012: 82013: 52014: 82015: 82016: 42017: 92018: 72019: 22020: 42021: 12022: 62023: 62024: 62025: 72026 (partial year): 8
2007high 11 (2008) · low 1 (2021)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FGE

257in 2025

2007: 316 days median2008: 214 days median2009: 160 days median2010: 81 days median2011: 114 days median2012: 96 days median2013: 161 days median2014: 156 days median2015: 79 days median2016: 49 days median2017: 59 days median2018: 215 days median2020: 121 days median2022: 101 days median2023: 199 days median2024: 188 days median2025: 257 days median2026 (partial year): 153 days median
2007high 316 (2007) · low 49 (2016)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FGE

1in 2024

2007: 542008: 932009: 182010: 322011: 22012: 42013: 32017: 12018: 432019: 132020: 12021: 272022: 212023: 192024: 12026 (partial year): 11
2007high 93 (2008) · low 0 (2014)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FGE

1,923in 2025

2007: 1,0062008: 1,4652009: 1,6552010: 1,4342011: 1,3212012: 1,1832013: 1,0602014: 1,2702015: 1,5432016: 1,4532017: 1,5152018: 1,6812019: 1,8962020: 2,1822021: 2,2972022: 1,7492023: 1,6152024: 1,9482025: 1,923
2007high 2,297 (2021) · low 1,006 (2007)2025

MAUDE reports naming product code FGE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20074316541,006
200811214931,465
20097160181,655
2010981321,434
2011911421,321
201289641,183
2013516131,060
2014815601,270
201587901,543
201644901,453
201795911,515
20187215431,681
20192—131,896
2020412112,182
20211—272,297
20226101211,749
20236199191,615
2024618811,948
2025725701,923
2026815311—

What is it indicated for?

The PALMAZ CORINTHIAN Transhepatic Biliary Stent is indicated for the palliation of malignant neoplasms in the biliary tree.

Certain sizes of the OPTA LP catheters are indicated for deployment of 6-10 mm diameter X 4-10 cm length PALMAZ CORINTHIAN Transhepatic Riliary Stents. The clinical indications for these stents are described in their Instructions for Use.

Additionally, the OPTA LP catheter is intended to dilatc stenoses i iliae, femoral, ilio-femoral, popliteal, infra popliteal and renal arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K991028: Cordis Palmaz Corinthian Transhepatic Biliary Stent and Accessories.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K991028

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026